Clinical trial / 2015
Chronic trans-resveratrol supplementation modulated cerebral blood flow and reduced fatigue ratings, but showed no interpretable cognitive effects in young adults.
In a randomised, double-blind, placebo-controlled study, 60 adults aged 18 to 30 years were given resveratrol or placebo for 28 days. Resveratrol modulated cerebral blood flow (CBF) parameters on day 1 as assessed by near-IR spectroscopy and significantly lowered subjective ratings of fatigue across the entire 28 days. Cognitive effects were limited to more accurate but slower serial subtraction performance on day 1, and improved 3-Back task accuracy before dose on day 28. Resveratrol significantly increased diastolic blood pressure on day 28 and resulted in higher resveratrol metabolite levels on day 28 compared with day 1.
- Study type
- Randomised, double-blind, placebo-controlled, parallel-groups study
- Who was studied
- 60 adults aged between 18 and 30 years
- What was measured
- Cognitive task performance, blood pressure, cerebral blood flow, subjective mood, sleep quality, and health questionnaires
THE PAPER
The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans.
Wightman EL, Haskell-Ramsay CF, Reay JL, Williamson G, Dew T, Zhang W, Kennedy DO. Br J Nutr, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.